- Home
- CRON vs LENZ Comparison
CRON vs LENZ Comparison
Compare CRON & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRON | LENZ |
|---|---|---|
| Founded | N/A | 2019 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 961.2M | 852.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CRON | LENZ |
|---|---|---|
| Price | $2.82 | $25.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $56.25 |
| AVG Volume (30 Days) | ★ 1.9M | 868.1K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $132,357,000.00 | $17,500,000.00 |
| Revenue This Year | $19.67 | N/A |
| Revenue Next Year | $30.56 | $204.72 |
| P/E Ratio | $29.63 | ★ N/A |
| Revenue Growth | ★ 19.00 | N/A |
| 52 Week Low | $1.60 | $16.54 |
| 52 Week High | $3.16 | $50.40 |
Technical Indicators
Market Signals| Indicator | CRON | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 71.81 | 37.39 |
| Support Level | $2.40 | $27.07 |
| Resistance Level | $2.55 | $29.02 |
| Average True Range (ATR) | 0.12 | 2.02 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 83.46 | 4.89 |
Price Performance
Historical ComparisonAbout CRON Cronos Group Inc.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.